Sernova Corp. (TSE:SVA – Get Free Report)’s share price was up 14.3% on Wednesday . The company traded as high as C$0.16 and last traded at C$0.16. Approximately 430,149 shares changed hands during trading, an increase of 276% from the average daily volume of 114,394 shares. The stock had previously closed at C$0.14.
Sernova Stock Performance
The stock has a 50 day simple moving average of C$0.15 and a 200 day simple moving average of C$0.16. The company has a quick ratio of 18.11, a current ratio of 0.02 and a debt-to-equity ratio of -68.92. The company has a market cap of C$53.87 million, a price-to-earnings ratio of -3.20 and a beta of -0.06.
About Sernova
Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem-cell derived islet-like clusters in collaboration with Evotec to create bio-hybrid organs to treat T1D. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This innovative approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on T1D and thyroid disorders.
Featured Stories
- Five stocks we like better than Sernova
- Silver paying 20% dividend. Plus 68% share gains
- Is Elon about to trigger another 315X opportunity?
- What happened in Cyprus could be coming here
- Unlocked: Elon Musk’s Next Big IPO
- Trade this between 9:30 and 10:45 am EST
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
